361 Capital’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-27,270
| Closed | -$1.69M | – | 367 |
|
|
2019
Q3 | $1.69M | Sell |
27,270
-622
| -2% | -$38.6K | 0.31% | 164 |
|
|
2019
Q2 | $1.99M | Sell |
27,892
-1,908
| -6% | -$136K | 0.35% | 156 |
|
|
2019
Q1 | $2.34M | Buy |
+29,800
| New | +$2.34M | 0.41% | 140 |
|
|
2018
Q4 | – | Sell |
-10,948
| Closed | -$1.88M | – | 362 |
|
|
2018
Q3 | $1.88M | Sell |
10,948
-3,367
| -24% | -$577K | 0.41% | 77 |
|
|
2018
Q2 | $1.85M | Sell |
14,315
-2,936
| -17% | -$379K | 0.42% | 58 |
|
|
2018
Q1 | $1.78M | Buy |
+17,251
| New | +$1.78M | 0.44% | 52 |
|
|
2017
Q4 | – | Sell |
-24,710
| Closed | -$2.1M | – | 273 |
|
|
2017
Q3 | $2.1M | Buy |
+24,710
| New | +$2.1M | 0.4% | 126 |
|
|
2016
Q1 | – | Sell |
-1,090
| Closed | -$74K | – | 125 |
|
|
2015
Q4 | $74K | Buy |
+1,090
| New | +$74K | 0.61% | 48 |
|